Dolutegravir, NRTI Combination Effective Second-Line Treatment For Patients With HIV Infection, Results Show
September 02, 2021
Infectious Disease Advisor (9/1, Gupta) reports a combination of dolutegravir with nucleoside reverse-transcriptase inhibitors (NRTI) “was an effective second-line treatment for patients with HIV infection, including those with extensive NRTI resistance a...